{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:25:07Z","timestamp":1794561907335,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,26]],"date-time":"2027-05-26T00:00:00Z","timestamp":1811289600000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["U24HG009650"],"award-info":[{"award-number":["U24HG009650"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["U24HG006834"],"award-info":[{"award-number":["U24HG006834"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["U24HG009649"],"award-info":[{"award-number":["U24HG009649"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymgme.2026.110156","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:29:29Z","timestamp":1779319769000},"page":"110156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Variant classification for mucopolysaccharidosis type I; ACMG\/AMP specification for IDUA from the ClinGen lysosomal diseases variant curation expert panel"],"prefix":"10.1016","volume":"148","author":[{"given":"Melanie","family":"Lacaria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Aschoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwen","family":"Chen-Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ellinwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam R.","family":"Farman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina Vlasova-St.","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Prout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelynn","family":"Roark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthavan","family":"Selvanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley C.","family":"Ratzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeksha","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraka","family":"Donti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Pinto e","family":"Vairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rehder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ymgme.2026.110156_bb0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.ymgme.2026.110156_bb0010","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/humu.23645","article-title":"ClinGen variant curation expert panel experiences and standardized processes for disease and gene-level specification of the ACMG\/AMP guidelines for sequence variant interpretation","volume":"39","author":"Rivera-Munoz","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2026.110156_bb0015","author":"ClinGen Variant Curation Expert Panel (VCEP) Protocol"},{"key":"10.1016\/j.ymgme.2026.110156_bb0025","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399408000550","article-title":"The mucopolysaccharidoses: a success of molecular medicine","volume":"10","author":"Clarke","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110156_bb0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10545-008-1040-5","article-title":"Pathogenic cascades in lysosomal disease-why so complex?","volume":"32","author":"Walkley","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4 Suppl","key":"10.1016\/j.ymgme.2026.110156_bb0035","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jpeds.2009.07.005","article-title":"Guidelines for the management of Mucopolysaccharidosis Type I","volume":"155","author":"Martins","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110156_bb0040","series-title":"GeneReviews","article-title":"Mucopolysaccharidosis Type I","author":"Clarke","year":"2002"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110156_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2007.01.011","article-title":"The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I","volume":"91","author":"Pastores","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110156_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6040091","article-title":"Newborn screening for Mucopolysaccharidosis I: moving forward learning from experience","volume":"6","author":"Clarke","year":"2020","journal-title":"Int. J. Neonatal Screen"},{"issue":"4","key":"10.1016\/j.ymgme.2026.110156_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cge.13583","article-title":"Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): insights from the international MPS I Registry","volume":"96","author":"Clarke","year":"2019","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110156_bb0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2021.03.002","article-title":"The natural history of neurocognition in MPS disorders: a review","volume":"133","author":"Shapiro","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110156_bb0065","author":"Lysosomal Diseases Variant Curation Expert Panel"},{"issue":"10","key":"10.1016\/j.ymgme.2026.110156_bb0070","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2017.26","article-title":"Using high-resolution variant frequencies to empower clinical genome interpretation","volume":"19","author":"Whiffin","year":"2017","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110156_bb0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13073-021-01004-8","article-title":"ClinGen variant curation Interface: a variant classification platform for the application of evidence criteria from ACMG\/AMP guidelines","volume":"14","author":"Preston","year":"2022","journal-title":"Genome Med."},{"issue":"7809","key":"10.1016\/j.ymgme.2026.110156_bb0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ymgme.2026.110156_bb0090","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"D1","key":"10.1016\/j.ymgme.2026.110156_bb0095","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgme.2026.110156_bb0100","author":"ClinGen Criteria Specification Registry"},{"issue":"11","key":"10.1016\/j.ymgme.2026.110156_bb0105","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/humu.23626","article-title":"Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion","volume":"39","author":"Abou Tayoun","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2026.110156_bb0110","series-title":"Application of the Acmg\/Amp Framework to Capture Evidence Relevant to Predicted and Observed Impact on Splicing: Recommendations from the Clingen Svi Splicing Subgroup","author":"Walker","year":"2023"},{"issue":"3","key":"10.1016\/j.ymgme.2026.110156_bb0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ymgme.2026.110156_bb0120","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","article-title":"Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria","volume":"109","author":"Pejaver","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110156_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.752797","article-title":"Which is the best in silico program for the missense variations in IDUA gene? A comparison of 33 programs plus a conservation score and evaluation of 586 missense variants","volume":"8","author":"Borges","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"11","key":"10.1016\/j.ymgme.2026.110156_bb0130","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/humu.23642","article-title":"Updated recommendation for the benign stand-alone ACMG\/AMP criterion","volume":"39","author":"Ghosh","year":"2018","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110156_bb0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymgme.2017.05.016","article-title":"Epidemiology of mucopolysaccharidoses","volume":"121","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110156_bb0140","unstructured":"SVI recommendation for absence\/rarity (PM2) - Version 1.0. 2020 Oct 1, 2025; Available from: https:\/\/clinicalgenome.org\/site\/assets\/files\/5182\/pm2_-_svi_recommendation_-_approved_sept2020.pdf."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110156_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-019-0690-2","article-title":"Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework","volume":"12","author":"Brnich","year":"2019","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110156_bb0150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41525-024-00457-1","article-title":"Functional assessment of IDUA variants of uncertain significance identified by newborn screening","volume":"9","author":"Yu","year":"2024","journal-title":"NPJ Genom. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110156_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109131","article-title":"Combining clinically benign IDUA variants in cis reduces enzymatic activity of the resulting enzyme within the pathogenic range","volume":"145","author":"Yu","year":"2025","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"10.1016\/j.ymgme.2026.110156_bb0160","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nchembio.1357","article-title":"Insights into mucopolysaccharidosis I from the structure and action of alpha-L-iduronidase","volume":"9","author":"Bie","year":"2013","journal-title":"Nat. Chem. Biol."},{"issue":"36","key":"10.1016\/j.ymgme.2026.110156_bb0165","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1073\/pnas.1306939110","article-title":"Human alpha-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module","volume":"110","author":"Maita","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2026.110156_bb0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jmgm.2014.10.004","article-title":"Lessons from molecular modeling human alpha-L-iduronidase","volume":"54","author":"Figueiredo","year":"2014","journal-title":"J. Mol. Graph. Model."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110156_bb0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2013.10.005","article-title":"Structural and clinical implications of amino acid substitutions in alpha-L-iduronidase: insight into the basis of mucopolysaccharidosis type I","volume":"111","author":"Saito","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110156_bb0185","article-title":"Endogenous, non-reducing end glycosaminoglycan biomarkers are superior to internal disaccharide glycosaminoglycan biomarkers for newborn screening of mucopolysaccharidoses and GM1 gangliosidosis","volume":"140","author":"Herbst","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110156_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.ymgme.2026.110156_bb0195","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/gim.2018.42","article-title":"The ACMG\/AMP reputable source criteria for the interpretation of sequence variants","volume":"20","author":"Biesecker","year":"2018","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110156_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63940","article-title":"Long-term health outcomes of individuals with Pseudodeficiency alleles in IDUA may inform newborn screening practices for Mucopolysaccharidosis Type I","volume":"197","author":"Grady","year":"2025","journal-title":"Am. J. Med. Genet. A"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:23:17Z","timestamp":1794558197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226004397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1096719226004397"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110156","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variant classification for mucopolysaccharidosis type I; ACMG\/AMP specification for IDUA from the ClinGen lysosomal diseases variant curation expert panel","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110156"}}